Echo Street Capital Management’s Gilead Sciences GILD Stock Holding History

Echo Street Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,390	Closed	-$329K	–	173
2023 Q3	$329K	Buy	+4,390	New	+$338K	﹤0.01%	351
2023 Q2	–	Sell	-12,538	Closed	-$1.04M	–	510
2023 Q1	$1.04M	Buy	12,538 +7,760	+162%	+$643K	0.01%	121
2022 Q4	$410K	Buy	+4,778	New	+$378K	﹤0.01%	336
2022 Q2	–	Sell	-13,646	Closed	-$811K	–	616
2022 Q1	$811K	Buy	+13,646	New	+$872K	0.01%	279
2021 Q1	–	Sell	-6,444	Closed	-$375K	–	546
2020 Q4	$375K	Buy	+6,444	New	+$389K	﹤0.01%	294

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Echo Street Capital Management's GILD Position: Q4 2023 in Review

Echo Street Capital Management sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 4,390 shares — an estimated $329K sold.

Echo Street Capital Management first reported a position in GILD in Q4 2020 and held it in 5 quarters. The position peaked at $1.04M in Q1 2023. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

Echo Street Capital Management reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
Echo Street Capital Management sold 4,390 Gilead Sciences shares in Q4 2023, an estimated $329K.
Echo Street Capital Management first reported a position in Gilead Sciences in Q4 2020 and held it in 5 quarters.
Echo Street Capital Management's Gilead Sciences position peaked at $1.04M in Q1 2023.
1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.